Meeting Niche Market Needs
Improving Patients’ Quality of Life
Governance and Growth Through Innovation
Where Experience Meets Expertise
Beginning December 1, 2019, health care professionals who handle hazardous drugs will be required to comply with stricter standards. The guidance, issued by the United States Pharmacopeia (USP), will help ensure greater safety for the workers who handle hazardous drugs.
Specialty pharmaceutical company CMP Pharma, Inc. announced today that its Potassium Phosphates Injection, the first FDA Approved Potassium Phosphates Injection, is NOW Available. Health Care Providers have available for the first time an FDA approved potassium phosphates injection. The availability of this product will help alleviate supply concerns from previous market shortages of this critical phosphate repletion treatment. CMP Pharma’s Potassium Phosphates Injection is now available from National and Regional wholesalers.